Allergan News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

02.05.18	Paradigm Spine Receives FDA Pre-Market Approval (PMA) For First Of Its Kind Disposable Instrument Kit (PR Newswire)
01.11.17	IKEA Canada prolonge son partenariat avec le Club des petits déjeuners pour soutenir le développement des jeunes enfants dans des collectivités d'un océan à l'autre. (PR Newswire)
21.09.17	Sphere ETFs Announces a Revision to September 2017 ex-Dividend Date (PR Newswire)
06.04.17	Rivel Releases Unprecedented International Study on Guidance Showing Deep Concern over Consensus Earnings and Short-term Volatility (PR Newswire)
20.01.17	ADMP Waiting To See If 3rd Time Is Charm, FDA Nod For SGYP, Be All Ears For OTIC (RTTNews)
19.01.17	Allergan Announces FDA Approval Of RHOFADE Cream (RTTNews)
19.01.17	Allergan Announces FDA Approval Of RHOFADE™ (Oxymetazoline Hydrochloride) Cream, 1% For The Topical Treatment Of Persistent Facial Erythema Associated With Rosacea In Adults (PR Newswire)
18.01.17	Allergan To Pay $15 Mln Fine For Disclosure Failures During Merger Talks (RTTNews)
17.01.17	Allergan and Gedeon Richter Announce Positive Phase III Results for Ulipristal Acetate 5 and 10 mg in the Treatment of Uterine Fibroids (PR Newswire)
12.01.17	Allergan to Report Fourth Quarter and Full Year 2016 Earnings and Host Conference Call and Webcast (PR Newswire)
09.01.17	Allergan Purchases Option Right To Acquire Lysosomal Therapeutics - Quick Facts (RTTNews)
09.01.17	Allergan Enters Parkinson's Disease Through Option Arrangement with Lysosomal Therapeutics Inc. (LTI) for its Potential First-In-Class Breakthrough Compounds (PR Newswire)
05.01.17	Allergan to Present at Goldman Sachs Healthcare CEOs Unscripted Conference and Provides Preliminary Comments on 2017 Outlook (PR Newswire)
04.01.17	Allergan: FDA Accepts For Filing SNDA For Liletta (RTTNews)
04.01.17	FDA Accepts For Filing Supplemental New Drug Application (sNDA) For LILETTA® (levonorgestrel-releasing intrauterine system) 52 mg (PR Newswire)
04.01.17	Technical Reports on Generic Drugs Stocks -- Mylan, Allergan, Horizon Pharma, and Catalent (PR Newswire)
04.01.17	AGRX Fails To SECURE Investor Confidence, ITEK Hit Hard, CBAY Rises On Kowa Deal (RTTNews)
03.01.17	EQUITY UPDATE: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Allergan PLC - AGN (PR Newswire)
03.01.17	Allergan Announces FDA Approval of NATRELLE INSPIRA® SoftTouch Breast Implants (PR Newswire)
24.12.16	Class Action Lawsuit Filed in the United States District Court for the District of New Jersey Against Allergan plc on Behalf of Shareholders - Lead Plaintiff Deadline Remains January 3, 2017 -- AGN (PR Newswire)
22.12.16	Allergan plc Board of Directors Issues Statement on Company's Social Contract with Patients (PR Newswire)
22.12.16	Ironwood, Allergan Report Topline Phase IIb Data For Linaclotide CR-1 In IBS-C (RTTNews)
22.12.16	Ironwood, Allergan Report Topline Phase IIb Data For Linaclotide CR2 (RTTNews)
21.12.16	Allergan to Present at Goldman Sachs Healthcare CEOs Unscripted Conference (PR Newswire)
21.12.16	AKBA Inks Blockbuster Deal, AGN On Buying Spree, TSRO Gets FDA Date (RTTNews)
20.12.16	Allergan To Acquire LifeCell Corp Of Acelity For $2.9 Bln In Cash (RTTNews)
20.12.16	Allergan to Acquire Acelity L.P. Inc.'s LifeCell Corporation for $2.9 Billion (PR Newswire)
19.12.16	Salpeter Gitkin, LLP Informing Investors of Allergan plc of Securities Class Action Lawsuits (PR Newswire)
15.12.16	Allergan Announces Civil Resolution Concluding Federal Investigation into Forest Sales & Marketing Practices (PR Newswire)
15.12.16	Aegon Announces Management Changes (PR Newswire)
15.12.16	Aegon Announces Management Changes (PR Newswire)
09.12.16	Allergan Says Dissapointed In PTAB's Decision On RESTASIS Patents (RTTNews)
08.12.16	Allergan Comments on PTAB Decision Regarding Mylan's Petitions for Inter Partes Review (IPR) of RESTASIS® Patents (PR Newswire)
08.12.16	Aegon Accelerates Execution of Strategy and Increases Expense Savings (PR Newswire)
08.12.16	Aegon Accelerates Execution of Strategy and Increases Expense Savings (PR Newswire)
08.12.16	Aegon Accelerates Execution of Strategy and Increases Expense Savings (PR Newswire)
02.12.16	Amgen And Allergan Submit Biosimilar Marketing Authorization Application To European Medicines Agency For ABP 215, A Biosimilar Candidate To Bevacizumab (PR Newswire)
02.12.16	Allergan Provides Update on Accelerated Share Repurchase (ASR) Program (PR Newswire)
02.12.16	Allergan Announces Settlement Of Patent Litigation On DELZICOL (RTTNews)
02.12.16	Allergan Announces Settlement Of Patent Litigation On DELZICOL (RTTNews)
02.12.16	Allergan Announces Settlement of a DELZICOL® (mesalamine) Patent Litigation (PR Newswire)
01.12.16	Technical Reports on Generic Drugs Stocks -- Mylan, Horizon Pharma, Allergan, and Catalent (PR Newswire)
28.11.16	Aegon to Appoint Matthew Rider as CFO (PR Newswire)
28.11.16	Aegon to Appoint Matthew Rider as CFO (PR Newswire)
23.11.16	Allergan PLC Investors With Losses In Excess of $1,000,000 Are Reminded to Contact the Rosen Law Firm Regarding the Important Deadline in Class Action filed by Firm - AGN (PR Newswire)
22.11.16	Allergan Acquires Chase Pharmaceuticals to Expand CNS R&D Pipeline and Build on Commitment to Alzheimer's Disease (PR Newswire)
22.11.16	Allergan Gets FDA Clearance For Xen Glaucoma Treatment (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Alcon	77.62	1.81 %	K V
CieFinRichemont	122.35	0.99 %	K V
Lonza Grp	531.00	0.84 %	K V
Zurich Insur Gr	553.00	0.18 %	K V
Novartis	91.93	0.00 %	K V
ABB	49.54	-0.84 %	K V
Swisscom	504.00	-0.98 %	K V
Sika	228.60	-1.12 %	K V
Holcim	88.42	-1.51 %	K V
UBS Group	27.76	-2.08 %	K V

mehr

22:34		Dow Jones aktuell: Dow Jones zum Handelsende in Grün
20:04		Börse New York: Dow Jones wenig verändert
18:01		Verluste in New York: Dow Jones legt den Rückwärtsgang ein
17:58		Börse Zürich: SMI letztendlich in Rot
16:02		S&P 500-Wert Pfizer-Aktie: So viel Verlust wäre bei einem Investment in Pfizer von vor einem Jahr angefallen
16:02		Dow Jones 30 Industrial-Papier Merck-Aktie: Wäre eine Merck-Investition von vor einem Jahr lukrativ gewesen?
16:02		Schwacher Handel in New York: Dow Jones zum Start mit Abgaben

22:34

Dow Jones aktuell: Dow Jones zum Handelsende in Grün

20:04

Börse New York: Dow Jones wenig verändert

18:01

Verluste in New York: Dow Jones legt den Rückwärtsgang ein

17:58

Börse Zürich: SMI letztendlich in Rot

16:02

S&P 500-Wert Pfizer-Aktie: So viel Verlust wäre bei einem Investment in Pfizer von vor einem Jahr angefallen

16:02

Dow Jones 30 Industrial-Papier Merck-Aktie: Wäre eine Merck-Investition von vor einem Jahr lukrativ gewesen?